GlassScriptPhysician profile
Heidi E Schneider
NPI 1699489351
$6,393.26
in general payments reported to CMS, 2019-2025
36 companies · $2,498 in 2025
The $2,498 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,027 · 2024: $2,869 · 2025: $2,498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,393.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,070.03 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $850.47 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $660.04 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $648.52 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Phathom Pharmaceuticals, INC. | $435.94 | 2024-2025 | Voquezna |
| Amgen INC. | $301.90 | 2023-2025 | Evenity, Prolia, Repatha |
| Xeris Pharmaceuticals, INC. | $278.76 | 2024-2025 | Keveyis, Gvoke Hypopen, Recorlev |
| Pfizer INC. | $267.04 | 2023-2025 | |
| Phadia US INC. | $234.26 | 2024-2025 | Immunocap |
| Exact Sciences Corporation | $209.68 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $181.83 | 2023-2024 | Dificid, Gardasil 9, Vaxneuvance |
| Bayer Healthcare Pharmaceuticals INC. | $160.22 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $141.67 | 2024-2025 | Cobenfy, Eliquis |
| Corcept Therapeutics | $135.49 | 2024-2025 | Korlym |
| Astellas Pharma US INC | $110.74 | 2023-2024 | Veozah |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.